Form 4 · Filed Jun 3, 2026, 10:02 PM UTC
RIGL/RIGEL PHARMACEUTICALS INC
Santos David A — EVP, Chief Commercial Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | F | other | 874 | $30 | $26,098 | 61,996 |
Source: SEC EDGAR raw filing ↗ · Accession 0000905148-26-002810